Treatment and physiology in Parkinson's disease and dystonia: Using transcranial magnetic stimulation to uncover the mechanisms of action

Current Neurology and Neuroscience Reports

Volumn 14, Issue 6, 2014, Pages

  Wagle Shukla, Aparna ^a   Vaillancourt, David E ^a,b  

^a UNIVERSITY OF FLORIDA   (United States)

^b University of Florida   (United States)

Author keywords

Dystonia; Parkinson's disease; Transcranial magnetic stimulation

Indexed keywords

BOTULINUM TOXIN A; LEVODOPA;

BASAL GANGLION; BLEPHAROSPASM; BRAIN DEPTH STIMULATION; DOPAMINERGIC SYSTEM; DYSTONIA; ELECTROMYOGRAPHY; EVOKED MUSCLE RESPONSE; GENETIC POLYMORPHISM; GLOBUS PALLIDUS; HUMAN; LONG TERM DEPRESSION; LONG TERM POTENTIATION; MAGNETIC FIELD; NERVE CELL PLASTICITY; NERVE CONDUCTION; NERVE EXCITABILITY; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PATHOPHYSIOLOGY; PERCEPTIVE THRESHOLD; PREMOTOR CORTEX; PRIMARY MOTOR CORTEX; PYRAMIDAL NERVE CELL; REVIEW; SENSORIMOTOR INTEGRATION; SUBTHALAMIC NUCLEUS; TRANSCRANIAL MAGNETIC STIMULATION; BRAIN; DRUG EFFECTS; PROCEDURES;

BRAIN; DYSTONIA; HUMANS; PARKINSON DISEASE; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84900546101     PISSN: 15284042     EISSN: 15346293     Source Type: Journal    
DOI: 10.1007/s11910-014-0449-5     Document Type: Review

References (108)

1. Hallett M. Transcranial magnetic stimulation: a primer. Neuron. 2007;55(2):187-99.
2. Merton PA, Morton HB. Stimulation of the cerebral cortex in the intact human subject. Nature. 1980;285(5762):227.
3. Barker AT, Jalinous R, Freeston IL. Non-invasive magnetic stimulation of human motor cortex. Lancet. 1985;1(8437):1106-7.
4. Amassian VE, Cracco RQ, Maccabee PJ, Cracco JB, Rudell A, Eberle L. Suppression of visual perception by magnetic coil stimulation of human occipital cortex. Electroencephalogr Clin Neurophysiol. 1989;74(6):458-62.
5. Cantello R. Applications of transcranial magnetic stimulation in movement disorders. J Clin Neurophysiol. 2002;19(4):272-93.
6. Chen R. Interactions between inhibitory and excitatory circuits in the human motor cortex. Exp Brain Res. 2004;154(1):1-10.
7. Rothwell JC. Techniques and mechanisms of action of transcranial stimulation of the human motor cortex. J Neurosci Methods. 1997;74(2):113-22.
8. Pascual-Leone A, Tormos JM, Keenan J, Tarazona F, Canete C, Catala MD. Study and modulation of human cortical excitability with transcranial magnetic stimulation. J Clin Neurophysiol. 1998;15(4):333-43.
9. Kujirai T, Caramia MD, Rothwell JC, Day BL, Thompson PD, Ferbert A, et al. Corticocortical inhibition in human motor cortex. J Physiol. 1993;471:501-19.
10. Sanger TD, Garg RR, Chen R. Interactions between two different inhibitory systems in the human motor cortex. J Physiol. 2001;530(2):307-17.
11. Roshan L, Paradiso GO, Chen R. Two phases of short-interval intracortical inhibition. Exp Brain Res. 2003;151(3):330-7.
12. Chen R, Yung D, Li JY. Organization of ipsilateral excitatory and inhibitory pathways in the human motor cortex. J Neurophysiol. 2003;89(3):1256-64.
13. Valls-Sole J, Pascual-Leone A, Brasil-Neto JP, Cammarota A, McShane L, Hallett M. Abnormal facilitation of the response to transcranial magnetic stimulation in patients with Parkinson's disease. Neurology. 1994;44(4):735-41.
14. Wassermann EM, Samii A, Mercuri B, Ikoma K, Oddo D, Grill SE, et al. Responses to paired transcranial magnetic stimuli in resting, active, and recently activated muscles. Exp Brain Res. 1996;109(1):158-63.
15. Priori A, Berardelli A, Inghilleri M, Accornero N, Manfredi M. Motor cortical inhibition and the dopaminergic system. Pharmacological changes in the silent period after transcranial brain stimulation in normal subjects, patients with Parkinson's disease and drug-induced parkinsonism. Brain. 1994;117(2):317-23.
16. Chen R, Wassermann EM, Canos M, Hallett M. Impaired inhibition in writer's cramp during voluntary muscle activation. Neurology. 1997;49(4):1054-9.
17. Ziemann U, Rothwell JC, Ridding MC. Interaction between intracortical inhibition and facilitation in human motor cortex. J Physiol. 1996;496(3):873-81.
18. Strafella AP, Paus T. Cerebral blood-flow changes induced by paired-pulse transcranial magnetic stimulation of the primary motor cortex. J Neurophysiol. 2001;85(6):2624-9.
19. Chen R, Corwell B, Hallett M. Modulation of motor cortex excitability by median nerve and digit stimulation. Exp Brain Res. 1999;129(1):77-86.
20. Forss N, Hari R, Salmelin R, Ahonen A, Hamalainen M, Kajola M, et al. Activation of the human posterior parietal cortex by median nerve stimulation. Exp Brain Res. 1994;99(2):309-15.
21. Allison T, McCarthy G, Wood CC, Darcey TM, Spencer DD, Williamson PD. Human cortical potentials evoked by stimulation of the median nerve. I. Cytoarchitectonic areas generating shortlatency activity. J Neurophysiol. 1989;62(3):694-710.
22. Classen J, Steinfelder B, Liepert J, Stefan K, Celnik P, Cohen LG, et al. Cutaneomotor integration in humans is somatotopically organized at various levels of the nervous system and is task dependent. Exp Brain Res. 2000;130(1):48-59.
23. Richardson SP, Bliem B, Lomarev M, Shamim E, Dang N, Hallett M. Changes in short afferent inhibition during phasicmovement in focal dystonia. Muscle Nerve. 2008;37(3):358-63.
24. Ugawa Y, Uesaka Y, Terao Y, Hanajima R, Kanazawa I. Magnetic stimulation over the cerebellum in humans. Ann Neurol. 1995;37(6):703-13.
25. Werhahn KJ, Taylor J, Ridding M, Meyer BU, Rothwell JC. Effect of transcranial magnetic stimulation over the cerebellum on the excitability of human motor cortex. Electroencephalogr Clin Neurophysiol. 1996;101(1):58-66.
26. Ugawa Y, Day BL, Rothwell JC, Thompson PD, Merton PA, Marsden CD. Modulation of motor cortical excitability by electrical stimulation over the cerebellum in man. J Physiol. 1991;441:57-72.
27. Pinto AD, Chen R. Suppression of the motor cortex by magnetic stimulation of the cerebellum. Exp Brain Res. 2001;140(4):505-10.
28. Pinto AD, Lang AE, Chen R. The cerebellothalamocortical pathway in essential tremor. Neurology. 2003;60(12):1985-7.
29. Ni Z, Pinto AD, Lang AE, Chen R. Involvement of the cerebellothalamocortical pathway in Parkinson disease. Ann Neurol. 2010;68(6):816-24.
30. Butler AJ, Wolf SL. Putting the brain on the map: use of transcranial magnetic stimulation to assess and induce cortical plasticity of upper-extremity movement. Phys Ther. 2007;87(6):719-36.
31. Feldman DE. The spike-timing dependence of plasticity. Neuron. 2012;75(4):556-71.
32. Malenka RC, Bear MF. LTP and LTD: an embarrassment of riches. Neuron. 2004;44(1):5-21.
33. Player MJ, Taylor JL, Alonzo A, Loo CK. Paired associative stimulation increases motor cortex excitability more effectively than theta-burst stimulation. Clin Neurophysiol. 2012;123(11):2220-6.
34. Wu AD, Fregni F, Simon DK, Deblieck C, Pascual-Leone A. Noninvasive brain stimulation for Parkinson's disease and dystonia. Neurotherapeutics. 2008;5(2):345-61.
35. Zangen A, Roth Y, Voller B, Hallett M. Transcranial magnetic stimulation of deep brain regions: evidence for efficacy of the H-coil. Clin Neurophysiol. 2005;116(4):775-9.
36. Epstein CM, Davey KR. Iron-core coils for transcranial magnetic stimulation. J Clin Neurophysiol. 2002;19(4):376-81.
37. Jahanshahi M, Brown RG, Marsden CD. A comparative study of simple and choice reaction time in Parkinson's, Huntington's and cerebellar disease. J Neurol Neurosurg Psychiatry. 1993;56(11):1169-77.
38. Phillips JG, Martin KE, Bradshaw JL, Iansek R. Could bradykinesia in Parkinson's disease simply be compensation? J Neurol. 1994;241(7):439-47.
39. Cunnington R, Iansek R, Thickbroom GW, Laing BA, Mastaglia FL, Bradshaw JL, et al. Effects of magnetic stimulation over supplementary motor area on movement in Parkinson's disease. Brain. 1996;119(3):815-22.
40. Ridding MC, Inzelberg R, Rothwell JC. Changes in excitability of motor cortical circuitry in patients with Parkinson's disease. Ann Neurol. 1995;37(2):181-8.
41. Filippi MM, Oliveri M, Pasqualetti P, Cicinelli P, Traversa R, Vernieri F, et al. Effects of motor imagery on motor cortical output topography in Parkinson's disease. Neurology. 2001;57(1):55-61.
42. Snider SR, Fahn S, Isgreen WP, Cote LJ. Primary sensory symptoms in parkinsonism. Neurology. 1976;26(5):423-9.
43. Jobst EE, Melnick ME, Byl NN, Dowling GA, Aminoff MJ. Sensory perception in Parkinson disease. Arch Neurol. 1997;54(4):450-4.
44. Maschke M, Gomez CM, Tuite PJ, Konczak J. Dysfunction of the basal ganglia, but not the cerebellum, impairs kinaesthesia. Brain. 2003;126(10):2312-22.
45. Sailer A, Molnar GF, Paradiso G, Gunraj CA, Lang AE, Chen R. Short and long latency afferent inhibition in Parkinson's disease. Brain. 2003;126(8):1883-94.
46. .• Kishore A, Popa T, Velayudhan B, Joseph T, Balachandran A, Meunier S. Acute dopamine boost has a negative effect on plasticity of the primarymotor cortex in advanced Parkinson's disease. Brain. 2012;135(7):2074-88. Kishore et al. used a TMS-based plasticity protocol in their study of PD patients. They found levodopa challenge worsens LTD-like plasticity and worsens LTP-like plasticity in nondyskinetic motor fluctuators.
47. Cunic D, Roshan L, Khan FI, Lozano AM, Lang AE, Chen R. Effects of subthalamic nucleus stimulation on motor cortex excitability in Parkinson's disease. Neurology. 2002;58(11):1665-72.
48. Dauper J, Peschel T, Schrader C, Kohlmetz C, Joppich G, Nager W, et al. Effects of subthalamic nucleus (STN) stimulation on motor cortex excitability. Neurology. 2002;59(5):700-6.
49. Sailer A, Cunic DI, Paradiso GO, Gunraj CA, Wagle-Shukla A, Moro E, et al. Subthalamic nucleus stimulation modulates afferent inhibition in Parkinson disease. Neurology. 2007;68(5):356-63.
50. .• Wagle Shukla A, Moro E, Gunraj C, Lozano A, Hodaie M, Lang A, et al. Long-term subthalamic nucleus stimulation improves sensorimotor integration and proprioception. J Neurol Neurosurg Psychiatry. 2013;84(9):1020-8. Wagle Shukla et al. conducted a longitudinal study in PD patients and found that chronic STN DBS is required to correct the abnormal sensorimotor integration.
51. .• Kojovic M, Caronni A, Bologna M, Rothwell JC, Bhatia KP, Edwards MJ. Botulinum toxin injections reduce associative plasticity in patients with primary dystonia. Mov Disord. 2011;26(7):1282-9. Kojovic et al. found SICI is corrected and the PAS effect is reduced at the peak dose effects of botulinum toxin injections in patients with dystonia.
52. .• Ruge D, Tisch S, Hariz MI, Zrinzo L, Bhatia KP, Quinn NP, et al. Deep brain stimulation effects in dystonia: time course of electrophysiological changes in early treatment. Mov Disord. 2011;26(10):1913-21. Ruge et al. examined dystonia patients who underwent bilateral GPi DBS surgery. They used TMS to find abnormalities in the inhibitory circuit (SICI) are corrected at 1 month; however, at 6 months after GPi DBS surgery, the plasticity response, which is abnormally enhanced in dystonia, becomes reduced.
53. Buhmann C, Gorsler A, Baumer T, Hidding U, Demiralay C, Hinkelmann K, et al. Abnormal excitability of premotor-motor connections in de novo Parkinson's disease. Brain. 2004;127(12):2732-46.
54. Ahlskog JE, Muenter MD. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov Disord. 2001;16(3):448-58.
55. Cotzias GC, Papavasiliou PS, Gellene R. Modification of Parkinsonism - chronic treatment with L-dopa. N Engl J Med. 1969;280(7):337-45.
56. Chase TN. Striatal plasticity and extrapyramidal motor dysfunction. Parkinsonism Relat Disord. 2004;10(5):305-13.
57. Wagle Shukla A, Okun MS. Surgical treatment of Parkinson's disease: patients, targets, devices, and approaches. Neurotherapeutics. 2014;11(1):47-59.
58. Hutchison WD, Allan RJ, Opitz H, Levy R, Dostrovsky JO, Lang AE, et al. Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease. Ann Neurol. 1998;44(4):622-8.
59. Hamani C, Saint-Cyr JA, Fraser J, Kaplitt M, Lozano AM. The subthalamic nucleus in the context of movement disorders. Brain. 2004;127(1):4-20.
60. Vitek JL. Mechanisms of deep brain stimulation: excitation or inhibition. Mov Disord. 2002;17 Suppl 3:S69-72.
61. Hamani C, Richter E, Schwalb JM, Lozano AM. Bilateral subthalamic nucleus stimulation for Parkinson's disease: a systematic review of the clinical literature. Neurosurgery. 2005;56(6):1313-21. discussion 1321-4.
62. Ashby P, Paradiso G, Saint-Cyr JA, Chen R, Lang AE, Lozano AM. Potentials recorded at the scalp by stimulation near the human subthalamic nucleus. Clin Neurophysiol. 2001;112(3):431-7.
63. MacKinnon CD, Webb RM, Silberstein P, Tisch S, Asselman P, Limousin P, et al. Stimulation through electrodes implanted near the subthalamic nucleus activates projections to motor areas of cerebral cortex in patients with Parkinson's disease. Eur J Neurosci. 2005;21(5):1394-402.
64. Kuriakose R, Saha U, Castillo G, Udupa K, Ni Z, Gunraj C, et al. The nature and time course of cortical activation following subthalamic stimulation in Parkinson's disease. Cereb Cortex. 2010;20(8):1926-36.
65. Strafella AP, Vanderwerf Y, Sadikot AF. Transcranial magnetic stimulation of the human motor cortex influences the neuronal activity of subthalamic nucleus. Eur J Neurosci. 2004;20(8):2245-9.
66. Gaynor LM, Kuhn AA, Dileone M, Litvak V, Eusebio A, Pogosyan A, et al. Suppression of beta oscillations in the subthalamic nucleus following cortical stimulation in humans. Eur J Neurosci. 2008;28(8):1686-95.
67. Chen R, Garg RR, Lozano AM, Lang AE. Effects of internal globus pallidus stimulation on motor cortex excitability. Neurology. 2001;56(6):716-23.
68. Bressman SB. Dystonia. Curr Opin Neurol. 1998;11(4):363-72.
69. Fahn S, Bressman SB, Marsden CD. Classification of dystonia. Adv Neurol. 1998;78:1-10.
70. Berardelli A, Rothwell JC, Hallett M, Thompson PD, Manfredi M, Marsden CD. The pathophysiology of primary dystonia. Brain. 1998;121(7):1195-212.
71. Chen R, Hallett M. Focal dystonia and repetitivemotion disorders. Clin Orthop Relat Res. 1998;351:102-6.
72. Espay AJ, Morgante F, Purzner J, Gunraj CA, Lang AE, Chen R. Cortical and spinal abnormalities in psychogenic dystonia. Ann Neurol. 2006;59(5):825-34.
73. Quartarone A, Rizzo V, Terranova C, Morgante F, Schneider S, Ibrahim N, et al. Abnormal sensorimotor plasticity in organic but not in psychogenic dystonia. Brain. 2009;132(10):2871-7.
74. Abbruzzese G, Marchese R, Buccolieri A, Gasparetto B, Trompetto C. Abnormalities of sensorimotor integration in focal dystonia: a transcranial magnetic stimulation study. Brain. 2001;124(3):537-45.
75. Martino D, Defazio G, Alessio G, Abbruzzese G, Girlanda P, Tinazzi M, et al. Relationship between eye symptoms and blepharospasm: a multicenter case-control study. Mov Disord. 2005;20(12):1564-70.
76. Bara-Jimenez W, Shelton P, Hallett M. Spatial discrimination is abnormal in focal hand dystonia. Neurology. 2000;55(12):1869-73.
77. Bara-Jimenez W, Catalan MJ, Hallett M, Gerloff C. Abnormal somatosensory homunculus in dystonia of the hand. Ann Neurol. 1998;44(5):828-31.
78. Nelson AJ, Blake DT, Chen R. Digit-specific aberrations in the primary somatosensory cortex in writer's cramp. Ann Neurol. 2009;66(2):146-54.
79. Butterworth S, Francis S, Kelly E, McGlone F, Bowtell R, Sawle GV. Abnormal cortical sensory activation in dystonia: an fMRI study. Mov Disord. 2003;18(6):673-82.
80. Murase N, Kaji R, Shimazu H, Katayama-Hirota M, Ikeda A, Kohara N, et al. Abnormal premovement gating of somatosensory input in writer's cramp. Brain. 2000;123(9):1813-29.
81. Kessler KR, Ruge D, Ilic TV, Ziemann U. Short latency afferent inhibition and facilitation in patients with writer's cramp. Mov Disord. 2005;20(2):238-42.
82. Pirio Richardson S, Bliem B, Voller B, Dang N, Hallett M. Long-latency afferent inhibition during phasic finger movement in focal hand dystonia. Exp Brain Res. 2009;193(2):173-9.
83. Daskalakis ZJ, Paradiso GO, Christensen BK, Fitzgerald PB, Gunraj C, Chen R. Exploring the connectivity between the cerebellum and motor cortex in humans. J Physiol. 2004;557(2):689-700.
84. Hubsch C, Roze E, Popa T, Russo M, Balachandran A, Pradeep S, et al. Defective cerebellar control of cortical plasticity in writer's cramp. Brain. 2013;136(7):2050-62.
85. Quartarone A, Bagnato S, Rizzo V, Siebner HR, Dattola V, Scalfari A, et al. Abnormal associative plasticity of the human motor cortex in writer's cramp. Brain. 2003;126(12):2586-96.
86. Edwards MJ, Huang YZ, Mir P, Rothwell JC, Bhatia KP. Abnormalities in motor cortical plasticity differentiate manifesting and nonmanifesting DYT1 carriers. Mov Disord. 2006;21(12):2181-6.
87. Weise D, Schramm A, Stefan K, Wolters A, Reiners K, Naumann M, et al. The two sides of associative plasticity in writer's cramp. Brain. 2006;129(10):2709-21.
88. Tamura Y, Ueki Y, Lin P, Vorbach S, Mima T, Kakigi R, et al. Disordered plasticity in the primary somatosensory cortex in focal hand dystonia. Brain. 2009;132(3):749-55.
89. Ghilardi MF, Carbon M, Silvestri G, Dhawan V, Tagliati M, Bressman S, et al. Impaired sequence learning in carriers of the DYT1 dystonia mutation. Ann Neurol. 2003;54(1):102-9.
90. Priori A, Berardelli A, Mercuri B, Manfredi M. Physiological effects produced by botulinum toxin treatment of upper limb dystonia. Changes in reciprocal inhibition between forearm muscles. Brain. 1995;118(3):801-7.
91. Trompetto C, Curra A, Buccolieri A, Suppa A, Abbruzzese G, Berardelli A. Botulinum toxin changes intrafusal feedback in dystonia: a study with the tonic vibration reflex. Mov Disord. 2006;21(6):777-82.
92. Curra A, Trompetto C, Abbruzzese G, Berardelli A. Central effects of botulinum toxin type A: evidence and supposition. Mov Disord. 2004;19 Suppl 8:S60-4.
93. Filippi GM, Errico P, Santarelli R, Bagolini B, Manni E. Botulinum A toxin effects on rat jaw muscle spindles. Acta Otolaryngol. 1993;113(3):400-4.
94. 125I-labelled botulinum A neurotoxin: pharmacokinetics in cats after intramuscular injection. Naunyn Schmiedeberg's Arch Pharmacol. 1976;292(2):161-5.
95. Pauri F, Boffa L, Cassetta E, Pasqualetti P, Rossini PM. Botulinum toxin type-Atreatment in spastic paraparesis: a neurophysiological study. J Neurol Sci. 2000;181(1-2):89-97.
96. Byrnes ML, Thickbroom GW, Wilson SA, Sacco P, Shipman JM, Stell R, et al. The corticomotor representation of upper limb muscles in writer's cramp and changes following botulinum toxin injection. Brain. 1998;121(5):977-88.
97. Gilio F, Curra A, Lorenzano C, Modugno N, Manfredi M, Berardelli A. Effects of botulinum toxin type A on intracortical inhibition in patients with dystonia. Ann Neurol. 2000;48(1):20-6.
98. Quartarone A, Sant'Angelo A, Battaglia F, Bagnato S, Rizzo V, Morgante F, et al. Enhanced long-term potentiation-like plasticity of the trigeminal blink reflex circuit in blepharospasm. J Neurosci. 2006;26(2):716-21.
99. Vidailhet M, Vercueil L, Houeto JL, Krystkowiak P, Benabid AL, Cornu P, et al. Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. N Engl J Med. 2005;352(5):459-67.
100. Coubes P, Roubertie A, Vayssiere N, Hemm S, Echenne B. Treatment of DYT1-generalised dystonia by stimulation of the internal globus pallidus. Lancet. 2000;355(9222):2220-1.
101. Volkmann J, Allert N, Voges J, Sturm V, Schnitzler A, Freund HJ. Long-term results of bilateral pallidal stimulation in Parkinson's disease. Ann Neurol. 2004;55(6):871-5.
102. Cif L, Vasques X, Gonzalez V, Ravel P, Biolsi B, Collod-Beroud G, et al. Long-term follow-up of DYT1 dystonia patients treated by deep brain stimulation: an open-label study. Mov Disord. 2010;25(3):289-99.
103. Ostrem JL, Starr PA. Treatment of dystonia with deep brain stimulation. Neurotherapeutics. 2008;5(2):320-30.
104. Andrews C, Aviles-Olmos I, Hariz M, Foltynie T. Which patients with dystonia benefit from deep brain stimulation? A metaregression of individual patient outcomes. J Neurol Neurosurg Psychiatry. 2010;81(12):1383-9.
105. Vasques X, Cif L, Gonzalez V, Nicholson C, Coubes P. Factors predicting improvement in primary generalized dystonia treated by pallidal deep brain stimulation. Mov Disord. 2009;24(6):846-53.
106. Ostrem JL, Racine CA, Glass GA, Grace JK, Volz MM, Heath SL, et al. Subthalamic nucleus deep brain stimulation in primary cervical dystonia. Neurology. 2011;76(10):870-8.
107. Tisch S, Limousin P, Rothwell JC, Asselman P, Zrinzo L, Jahanshahi M, et al. Changes in forearm reciprocal inhibition following pallidal stimulation for dystonia. Neurology. 2006;66(7):1091-3.
108. Tisch S, Limousin P, Rothwell JC, Asselman P, Quinn N, Jahanshahi M, et al. Changes in blink reflex excitability after globus pallidus internus stimulation for dystonia. Mov Disord. 2006;21(10):1650-5.